# LABU holdings: 169 positions > LABU holdings as of Oct 22, 2026: swaps on SPSIBI worth 231.5% of net assets, and the cash behind them. Every line, with its source and date. Data as of Oct 22, 2026. Rebuilt every trading night. LABU held swaps on SPSIBI worth 231.5% of its net assets on Oct 22, 2026. With the 68.5% it holds directly, its exposure is 300.0%. Source: Direxion (). | # | Holding | Ticker | Weight | | --- | --- | --- | --- | | 1 | SPSIBI swap asset leg | SPSIBI | 51.44% | | 2 | SPSIBI swap asset leg | SPSIBI | 49.87% | | 3 | SPSIBI swap asset leg | SPSIBI | 45.41% | | 4 | SPSIBI swap asset leg | SPSIBI | 36.06% | | 5 | SPSIBI swap asset leg | SPSIBI | 30.57% | | 6 | SPSIBI swap asset leg | SPSIBI | 15.50% | | 7 | SPSIBI swap asset leg | SPSIBI | 2.69% | | 8 | Moderna Inc | | 1.53% | | 9 | Natera Inc | | 1.24% | | 10 | Biogen Inc | | 1.23% | | 11 | Halozyme Therapeutics Inc | | 1.19% | | 12 | United Therapeutics Corp | | 1.18% | | 13 | Amgen Inc | | 1.17% | | 14 | Abbvie Inc | | 1.16% | | 15 | Exelixis Inc | | 1.14% | | 16 | Gilead Sciences Inc | | 1.10% | | 17 | Twist Bioscience Corp | | 1.10% | | 18 | Iovance Biotherapeutics Inc | | 1.10% | | 19 | Spyre Therapeutics Inc | | 1.09% | | 20 | Vertex Pharmaceuticals Inc | | 1.05% | | 21 | Regeneron Pharmaceuticals | | 1.04% | | 22 | Alkermes PLC | | 0.99% | | 23 | TG Therapeutics Inc | | 0.99% | | 24 | Protagonist Therapeutics Inc | | 0.98% | | 25 | PTC Therapeutics Inc | | 0.95% | | | Goldman Finl Sq Trsry Inst 506 | | 18.59% | | | Dreyfus Govt Cash Man Ins | | 15.83% | | | Goldman Sachs Fin Gov 465 Institut | | 0.35% | | | Dreyfus Trsry Securities Cash Mgmt | | 0.04% | The largest 25 of 169 positions are shown. All of them: https://etfiq.com/funds/labu/holdings/labu-holdings.csv (CSV) or https://etfiq.com/funds/labu/holdings/index.json (JSON). Fund page: https://etfiq.com/funds/labu Cite: ETFIQ, Holdings of LABU, data as of Oct 22, 2026. https://etfiq.com/funds/labu/holdings/